Advanced Filters
noise
Found 158 clinical trials

Time Restricted Eating for WeIght LoSs MainTenance-2

The TWIST 2.0 Study is a 12-month, 2-arm RCT in adults with recent weight loss. We will examine the efficacy of TRE on weight (Aim 1a) and fat mass (Aim 1b) regain, and describe changes in subjective appetite following a mixed-meal tolerance test (Exploratory).

25 - 65 years of age All Phase N/A
S Sarah Borden, MPH

Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

The goal of this clinical trial is to understand if genetic variations are associated with the amount of weight loss with diet and while taking an FDA-approved medication for weight loss. The main question[s] it aims to answer are: In Aim One, the investigators propose to rigorously test the hypothesis …

18 - 65 years of age All Phase 4
S Suzette Howton

Metabolic Adaptations to Weight Loss With and Without Exercise

Study Purpose: The combination of caloric restriction and exercise is the most common first-line treatment for obesity-related disorders, yet we know very little about how these two very different treatments work together. A deeper understanding about mechanisms underlying the health benefits of adding exercise to a weight loss program will …

18 - 40 years of age All Phase N/A
J Jessica Unick, PhD

Strategies for Improving Remote-based Weight Loss (PATH Trial)

The purpose of this study is to examine whether the addition of online yoga classes, compared to health and wellness classes, can improve the amount of weight loss produced from an Internet-based weight loss program. All individuals will receive a 12-month, automated Internet-based weight loss program. Following 3 months of …

18 - 65 years of age All Phase N/A
J Jared Greiner, MS

Adipocyte-Derived Extracellular Vesicles, Weight Loss, and Endothelial Function

Changes in adipose tissue biology are now recognized as a key factor underlying the increased risk of metabolic and cardiovascular disease with obesity. Clinical interest in adipocyte-derived extracellular vesicles (Ad-EVs) has intensified due to their potential as circulating biomarkers of adipose tissue health and systemic messengers, regulators and mediators of …

40 years of age All Phase N/A
S Sıdıka E. Yokuş

Intervention Study on Weight Loss in Patients With Obesity

The goal of this clinical trial is to evaluate the feasibility of using Socratic questioning as an alternative method for weight loss in adult patients with obesity (aged 18 to 65) in a primary care setting. The main question it aims to answer is: -Is Socratic questioning an effective alternative …

18 - 65 years of age All Phase N/A

Modified Intermittent Eating on Weight Loss (INTEREST-3 Trial)

Calorie restriction (CR) is the most important treatment for weighting loss. In recent years, two novel types of intermittent fasting recently have gained more attention: the 5:2 diet and time-restricted eating (TRE). TRE requires individuals to eat in a specified number of hours per day (typically 4 to 10 hours) …

18 - 75 years of age All Phase N/A
P Pamela A Reich

Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis

It is not known how much improvement in insulin regulated lipolysis (the breakdown of triglycerides) occurs following substantial, sustained weight loss. Researchers will test the effects of inflammation and lipolysis regulation in people before and after bariatric surgery (sleeve gastrectomy) to answer these questions.

18 - 65 years of age All Phase N/A
A Aoife Cotter, PhD

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

The prevalence of obesity is rising worldwide, both in low- and high-income countries, including people with HIV (PWH). Semaglutide's efficacy in achieving weight loss in obese PWH is still unexplored. The aim of this study is to assess the efficacy and safety of semaglutide in achieving greater weight loss compared …

18 years of age All Phase N/A
K Kuat P Oshakbayev, professor

Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

Background. The prevalence of type 2 diabetes mellitus (T2D) in the world is constantly increasing. Treatment of T2D is complicated by arterial hypertension and obesity (metabolic syndrome - MS). Cardiovascular complications are the main cause of death in patients with MS. Objective weight loss improves clinical and laboratory parameters in …

35 - 65 years of age All Phase N/A

Simplify language using AI